SCHEMBL3770180

SCHEMBL3770180

CC1CCN(CC(=O)N2CCN(C3CCCC3)CC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 4/20 0.51
GAA P10253 2/20 0.49
SIGMAR1 Q99720 1/20 0.47
NPC1 O15118 1/20 0.45
LMNA P02545 1/20 0.45
TSHR P16473 2/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 2/20 0.43
POLB P06746 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
PHGDH O43175 1/20 0.42
MGLL Q99685 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005092 0.97 KDM4E (0.52) ALDH1A1KDM4EGAASIGMAR1NPC1
SCHEMBL13005716 0.96 ALDH1A1 (0.54) ALDH1A1KDM4EGAASIGMAR1NPC1
SCHEMBL13005673 0.94 KDM4E (0.52) ALDH1A1KDM4EGAASIGMAR1NPC1
SCHEMBL3767809 0.89 SIGMAR1 (0.57) ALDH1A1KDM4EGAASIGMAR1LMNA
SCHEMBL13005070 0.87 KDM4E (0.65) ALDH1A1KDM4EGAASIGMAR1LMNA
SCHEMBL13005059 0.86 KDM4E (0.68) ALDH1A1KDM4EGAASIGMAR1LMNA
SCHEMBL3774024 0.86 KDM4E (0.68) ALDH1A1KDM4EGAASIGMAR1LMNA
SCHEMBL3774221 0.86 KDM4E (0.68) ALDH1A1KDM4EGAASIGMAR1LMNA
SCHEMBL3769500 0.86 KDM4E (0.68) ALDH1A1KDM4EGAASIGMAR1LMNA
SCHEMBL13005710 0.86 KDM4E (0.68) ALDH1A1KDM4EGAASIGMAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 ALDH1A1 1210/4885KDM4E 534/4885GAA 2143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.